
Opinion|Videos|September 27, 2024
The Importance of Clinical Trials in Infertility
Author(s)Jeffrey Dunn, PharmD, MBA
Jeffrey Dunn, Pharm.D., MBA, discusses how comparison trials for different assisted reproductive technologies (ARTs) are necessary to evaluate their relative efficacy, safety and cost-effectiveness, with specific focus on a trial comparing highly purified human menotropin (HP-hMG) and recombinant follicle-stimulating hormone (FSH), as well as a study examining the impact of health benefit design for ART on pregnancy outcomes.
Advertisement
Episodes in this series

Now Playing
Video content above is prompted by the following:
- Why is it necessary to have comparison trials for the different assisted reproductive technologies (ARTs) that are used in clinical practice?
- What was seen in the trial that compared highly purified human menotropin (HP-hMG) and recombinant follicle-stimulating hormone (FSH), and how do these results affect your decision-making?
- What was seen in a study that examined health benefit design for ART and its impact on pregnancy outcomes?
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
What UnitedHealth Group’s earnings call reveals about managed care trends
2
Slight Medicare Advantage payment increase sparks debate over risk adjustment
3
Don’t let ‘sleepmaxxing’ keep you up at night: Results from the 2025 American Academy of Sleep Medicine survey on sleep tracking
4
Weakened brain connections linked to cognitive deficits in schizophrenia
5




























